We provide you with 20 years of free, institutional-grade data for OPTN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of OPTN. Explore the full financial landscape of OPTN stock.
| Reported Date | CIK | Ticker | Type |
|---|
OptiNose, Inc(NASDAQ:OPTN) 
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery sys...
Website: http://www.optinose.com
Founded: 2000
Full Time Employees: 221
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about OPTN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.